Quest Diagnostics Q4 Profit Increases, Beats Estimates

Quest Diagnostics

136.51 CHF 6.72%

• Charts
• News
• Analysen

Kaufen Verkaufen

(RTTNews) - Quest Diagnostics (DGX) released earnings for its fourth quarter that increased from the same period last year and beat the Street estimates.

The company's bottom line totaled $222 million, or $1.95 per share. This compares with $192 million, or $1.70 per share, last year.

Excluding items, Quest Diagnostics reported adjusted earnings of $253 million or $2.23 per share for the period.

Analysts on average had expected the company to earn $2.18 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 14.6% to $2.621 billion from $2.288 billion last year.

Quest Diagnostics earnings at a glance (GAAP) :

-Earnings: $222 Mln. vs. $192 Mln. last year. -EPS: $1.95 vs. $1.70 last year. -Revenue: $2.621 Bln vs. $2.288 Bln last year.